ICYMI: Brad Gerstner & Rob Goldberg on the #1 Test for Heart Disease Prevention (You Probably Haven’t Taken)
1. Key Themes
Preventive diagnostics as an underexploited public health opportunity
The core thesis is that a cheap, existing test is being systematically underused due to legacy standards of care, not technological limits.
"It turns out that half of the people who have heart attacks every year have cholesterol in the normal zone."
Regulatory capture shaped medical standard of care
Gerstner argues the current cholesterol/stent-centric paradigm is a historical policy outcome, not necessarily the optimal clinical path.
"Who do you think won the lobby in Washington? The stent. The stent lobby won."
Personal tragedy as a catalyst for systemic change
The initiative is driven by lived experience — Silicon Valley figures using personal loss to fund and evangelize a public health campaign, mirroring how other health movements have scaled (e.g., breast cancer awareness).
"My brother had passed a running EKG 5 months before he dropped dead from heart disease, from undiagnosed heart disease."
Insurance coverage as the real lever for adoption
The bottleneck to scale isn't the technology or the cost — it's getting CMS/Medicare and Medicaid to classify the scan as standard of care.
"Doctors ultimately treat standard of care based upon what's covered by insurance."
2. Contrarian Perspectives
- Cholesterol is an insufficient risk marker despite being the dominant clinical metric. Gerstner contends the entire "normal LDL range" concept gives false reassurance, and that top preventive cardiologists privately use far stricter personal protocols than what's recommended to the public.
"At 30 or 35, I have them all take a CAC. If they have a non-zero score, I get them on a statin. I get their LDLs below 40."
- An unlicensed operator/investor, not a medical institution, is driving the change. Gerstner explicitly acknowledges he's not a physician but positions data literacy as sufficient standing to challenge medical consensus.
"I'm not a doctor, and some people who are doctors think I have no business talking about this, but I'm an analyst. I can read all the information."
- Universal screening won't be a silver bullet, but the leverage is still enormous. Even proponents concede scanning won't eliminate heart attacks — but argue the marginal impact is still historic in scale.
"Of course not, but you'll eliminate 80 to 90% of them."
3. Companies Identified
-
Center for Heart Attack Prevention — Nonprofit founded by Gerstner and Jason Chang to make CAC scans standard screening. Why mentioned: Central vehicle for the entire initiative (awareness, access, policy). Quote: "the team behind the Center for Heart Attack Prevention want to prevent more families from experiencing the same thing, pushing for earlier detection, broader access to CAC scans & changes to the standard of care."
-
Cleerly — AI radiology service for reading angiogram/plaque imaging. Why mentioned: Cited as a technology enabler for refining post-CAC follow-up diagnostics.
-
Siemens — Manufacturer of the calcium CT scanner used in the mobile trailer. Why mentioned: Underlying hardware provider making the mobile scanning model operationally possible.
-
Salesforce — Referenced as an example enterprise partner in the "buy one, give one" model. Quote: "We could get Marc Benioff & Salesforce to give it to all of his employees for free & then he would pay twice as much."
-
Altimeter — Gerstner's investment firm, funding/backing the mobile scanner purchase and initiative. Why mentioned: Signals a wealthy institutional investor personally bankrolling a public health moonshot.
4. People Identified
-
Brad Gerstner — Founder & CEO of Altimeter; purchased a mobile CAC scanner and co-founded the Center for Heart Attack Prevention. Why mentioned: Primary driver of the initiative and its public voice. Quote: "If we turn the calcium CT scan into the mammogram for the heart, we will save 50,000 lives a year."
-
Rob Goldberg — Brother of the late Dave Goldberg (former SurveyMonkey CEO); personal advocate for CAC screening. Why mentioned: Provides the emotional/personal case study anchoring the campaign. Quote: "We are losing people in the prime of their lives who have no need to die for something that is completely preventable and screenable."
-
Dave Goldberg — Former SurveyMonkey CEO who died at 47 of undiagnosed heart disease. Why mentioned: His death, despite passing a running EKG, is the motivating case for why traditional screening fails.
-
Jason Chang — Co-founder of the Center for Heart Attack Prevention alongside Gerstner. Why mentioned: Co-architect of the scanning initiative.
-
Sheryl Sandberg — Dave Goldberg's widow; co-author of Option B about grief after his death. Why mentioned: Connects the story to a broader cultural narrative around loss and resilience.
-
Chamath Palihapitiya — Friend of Dave Goldberg who helped arrange the autopsy confirming heart disease. Why mentioned: Ties the story to the broader "All-In"/besties network driving visibility.
5. Operating Insights
- "Buy one, give one" as a hybrid commercial/philanthropic distribution model: Companies pay $200/employee for scans, subsidizing free scans for underserved communities — a replicable model for scaling access-oriented health or social products while maintaining unit economics.
"So instead of paying $100, he would pay $200 & we could [give a free scan to underserved communities]."
-
Use influence networks and high-visibility events for pilot distribution: The scanner was tested at Altimeter's investor day, the All-In Summit, and NFL Super Bowl week — a case study in leveraging high-net-worth/high-visibility gatherings to generate media virality and rapid word-of-mouth adoption before going to policymakers.
-
Target policymakers directly as a distribution channel for standard-of-care change: Bringing the scanner to Capitol Hill is a savvy tactic — screening lawmakers themselves builds personal stakes into policy decisions.
"I can tell you that they are a target-rich population."
6. Overlooked Insights
-
EKGs have a meaningful false-negative rate that's rarely communicated to patients: "Rob cites a 4% false positive or false negative rate for EKGs, and said Dave's cardio training allowed his heart to compensate for the disease until it stopped." This suggests a systemic blind spot in fitness/health culture — that being visibly fit and passing standard cardiac stress tests can mask serious underlying disease.
-
CMS Administrator engagement suggests near-term regulatory catalyst: Gerstner's direct, repeated meetings with "CMS Administrator Dr. Oz" for potential Medicare/Medicaid coverage by year-end is a concrete, dateable policy catalyst that could be a leading indicator for a shift in diagnostic imaging reimbursement — relevant for investors tracking healthcare policy/medtech reimbursement plays.